Furin Prodomain ppFurin Enhances Ca

SOCE TRPC6 breast cancer calcium furin migration ppFurin viability

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
01 Apr 2021
Historique:
received: 17 02 2021
revised: 24 03 2021
accepted: 26 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

The intracellular calcium concentration ([Ca

Identifiants

pubmed: 33916304
pii: cancers13071670
doi: 10.3390/cancers13071670
pmc: PMC8037623
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : SIRIC-BRIO
ID : AAP2018
Organisme : La Ligue contre le cancer
ID : 2018
Organisme : Region Nouvelle Aquitaine
Organisme : MICINN
ID : BFU2016-74932-C2 and PID2019-104084GB-C21 and C22
Organisme : Junta de Extremadura-Fondo Europeo de Desarrollo Regional
ID : FEDER; Grants IB16046 and GR18061
Organisme : Junta de Extremadura
ID : TA18011

Références

Science. 2005 Jun 17;308(5729):1801-4
pubmed: 15879175
Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):83-91
pubmed: 19149690
PLoS One. 2010 Apr 09;5(4):e9992
pubmed: 20404912
Oncotarget. 2014 Jun 30;5(12):4195-210
pubmed: 24961901
Nat Genet. 2005 Jul;37(7):739-44
pubmed: 15924139
J Biol Chem. 2010 Jun 18;285(25):19173-83
pubmed: 20395295
J Biol Chem. 2004 Apr 30;279(18):18887-94
pubmed: 14761972
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130097
pubmed: 24493745
PLoS One. 2010 Jul 02;5(7):e11438
pubmed: 20625388
Curr Opin Physiol. 2020 Oct;17:89-95
pubmed: 32999945
Cell Death Dis. 2018 Oct 3;9(10):1015
pubmed: 30282964
Biochem J. 2020 Sep 18;477(17):3183-3197
pubmed: 32794568
FASEB J. 2019 Jul;33(7):8588-8599
pubmed: 31022353
Cancer Lett. 2020 Aug 1;484:40-49
pubmed: 32389711
Eur J Cell Biol. 2017 Aug;96(5):457-468
pubmed: 28624236
Cancer Lett. 2020 Mar 31;473:50-61
pubmed: 31899298
Int J Mol Sci. 2018 Dec 14;19(12):
pubmed: 30558192
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2502-11
pubmed: 25150047
Cancers (Basel). 2018 Sep 14;10(9):
pubmed: 30223530
Oncogene. 2005 Oct 20;24(46):6925-35
pubmed: 16007151
Br J Pharmacol. 2014 Feb;171(4):945-60
pubmed: 24460676
Blood. 2016 Feb 18;127(7):908-20
pubmed: 26634301
Cell Mol Life Sci. 2018 Dec;75(24):4525-4537
pubmed: 30105615
Cancer Cell Int. 2009 Aug 18;9:23
pubmed: 19689790
Clin Cancer Res. 2010 Jul 15;16(14):3607-17
pubmed: 20519360
Cancers (Basel). 2019 Oct 23;11(11):
pubmed: 31652779
Int J Mol Sci. 2020 Aug 05;21(16):
pubmed: 32764353
Gut. 2008 Nov;57(11):1573-82
pubmed: 18664504
Cancer Res. 2004 Sep 1;64(17):6225-32
pubmed: 15342408
Front Biosci. 2008 May 01;13:4960-71
pubmed: 18508561
J Diabetes Res. 2020 Jan 3;2020:6897390
pubmed: 31998809
Pflugers Arch. 2021 Apr;473(4):647-658
pubmed: 33386992
Nat Rev Mol Cell Biol. 2002 Oct;3(10):753-66
pubmed: 12360192
Clin Cancer Res. 2000 Nov;6(11):4432-41
pubmed: 11106264
Oncogene. 2020 Apr;39(17):3571-3587
pubmed: 32139876
Cell Calcium. 2020 Sep;90:102251
pubmed: 32683175
Int J Mol Sci. 2020 Oct 15;21(20):
pubmed: 33076541
J Clin Invest. 2006 Dec;116(12):3114-26
pubmed: 17099778
Onkologie. 2001 Jun;24(3):256-60
pubmed: 11455218
Nat Rev Cancer. 2003 May;3(5):330-8
pubmed: 12724731
J Biol Chem. 2007 Mar 16;282(11):7833-43
pubmed: 17197445
Cancer Res. 2007 Oct 1;67(19):9030-4
pubmed: 17909005
Am J Cancer Res. 2021 Jan 01;11(1):251-263
pubmed: 33520372
Am J Pathol. 2002 Jun;160(6):1921-35
pubmed: 12057895
PLoS One. 2009 Nov 26;4(11):e7700
pubmed: 19956642
Pflugers Arch. 2014 Oct;466(10):1921-32
pubmed: 24458591
JCI Insight. 2020 Jul 23;5(14):
pubmed: 32516140
Br J Pharmacol. 2015 Jul;172(14):3650-60
pubmed: 25847402
Carcinogenesis. 2014 Mar;35(3):528-36
pubmed: 24127186
Cell Calcium. 2013 Feb;53(2):139-51
pubmed: 23218667
J Biol Chem. 2011 Apr 8;286(14):12257-70
pubmed: 21321120
Cell Rep. 2018 Apr 10;23(2):522-534
pubmed: 29642009
Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164
pubmed: 31040712
Oncotarget. 2017 Feb 7;8(6):10437-10449
pubmed: 28060729
Cancer Res. 2019 Oct 1;79(19):5008-5021
pubmed: 31358531
Cancer Res. 2005 May 15;65(10):4162-71
pubmed: 15899807
J Clin Invest. 2003 Jun;111(11):1723-32
pubmed: 12782675

Auteurs

Jose J López (JJ)

Department of Physiology, University of Extremadura, 10003 Caceres, Spain.

Geraldine Siegfried (G)

LAMC, INSERM, University Bordeaux, U1029, F-33600 Pessac, France.

Carlos Cantonero (C)

Department of Physiology, University of Extremadura, 10003 Caceres, Spain.
LAMC, INSERM, University Bordeaux, U1029, F-33600 Pessac, France.

Fabienne Soulet (F)

LAMC, INSERM, University Bordeaux, U1029, F-33600 Pessac, France.

Jean Descarpentrie (J)

LAMC, INSERM, University Bordeaux, U1029, F-33600 Pessac, France.

Tarik Smani (T)

Department of Medical Physiology and Biophysics, University of Seville, 41009 Seville, Spain.
Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocío, 41013 Seville, Spain.

Iker Badiola (I)

Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country, 48940 Leioa, Spain.

Simon Pernot (S)

Bergonié Institute, 33000 Bordeaux, France.

Serge Evrard (S)

Bergonié Institute, 33000 Bordeaux, France.

Juan A Rosado (JA)

Department of Physiology, University of Extremadura, 10003 Caceres, Spain.

Abdel-Majid Khatib (AM)

LAMC, INSERM, University Bordeaux, U1029, F-33600 Pessac, France.
Bergonié Institute, 33000 Bordeaux, France.

Classifications MeSH